Acrivon Therapeutics, Inc. Insider Transaction

Mary Miller, Chief Legal Officer of Acrivon Therapeutics, Inc., reported a sale of 294 shares of Common Stock on October 5, 2026. The shares were sold at a weighted average price of $1.99 per share. This sale was to satisfy mandatory tax withholding requirements upon the vesting of restricted stock units. Following the transaction, Miller holds 81,715 shares. The sale was executed automatically by a broker to cover tax liabilities for a group of employees, including Miller, with proceeds allocated on a pro rata basis.